NEW YORK, Dec. 2 (GenomeWeb News) - The University of Michigan Medical School has won a $5.9 million grant from the National Institute of Allergy and Infectious Diseases to apply its proteomics research to help develop a widely used anthrax vaccine, the school said today.
In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.
